Who has invested in April Bio?

SM Sino Technology Investment, Yuhan Corporation are named among the investors backing April Bio.

April Bio Funding: $320M Raised, Series B (2026)

April Bio funding overview

April Bio is based in Chuncheon-si, South Korea. April Bio has raised $320M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in June 2026. The round record for April Bio runs through 2026; nothing later has been disclosed. Investors on record include SM Sino Technology Investment, Yuhan Corporation. 2 distinct backers are named across the disclosed rounds.

April Bio at a glance

Total raised: $320M
Latest round: Series B
Latest round date: June 2026
Headquarters: Chuncheon-si, South Korea
Notable investors: SM Sino Technology Investment, Yuhan Corporation

Frequently asked about April Bio funding

How much has April Bio raised?: April Bio has raised $320M in total disclosed funding across the rounds on record.
Who has invested in April Bio?: SM Sino Technology Investment, Yuhan Corporation are named among the investors backing April Bio.
What was the latest April Bio funding round?: The most recent disclosed round is a Series B, announced in June 2026.
Where is April Bio based?: April Bio is based in Chuncheon-si, South Korea.
When did April Bio last raise?: The last disclosed April Bio round closed in June 2026 at Series B.

April Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Chuncheon-si below to benchmark round size and investor mix.

April Bio Funding: $320M Raised, Series B (2026)

April Bio funding overview

April Bio at a glance

Frequently asked about April Bio funding

Companies related to April Bio (30)

Browse related funding lists (3)